Citigroup
ABVX icon

Citigroup’s Abivax ABVX Stock Holding History

Citigroup’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.1M Buy
11,151
+1,090
+11% +$131K ﹤0.01% 3241
2026
Q2 		$1.34M Buy
10,061
+8,332
+482% +$943K ﹤0.01% 3241
2026
Q1 		$193K Buy
1,729
+55
+3% +$6.51K ﹤0.01% 4022
2025
Q4 		$226K Buy
1,674
+1,623
+3,182% +$177K ﹤0.01% 3942
2025
Q3 		$4.33K Sell
51
-170,682
-100% -$10.5M ﹤0.01% 5268
2025
Q2 		$1.31M Sell
170,733
-13,506
-7% -$88K ﹤0.01% 3000
2025
Q1 		$1.15M Buy
+184,239
New +$1.25M ﹤0.01% 3145

Other funds holding ABVX

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Syquant Capital SAS
Syquant Capital SAS Paris, France $453M AUM 6.35% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Citigroup's ABVX Position: Q3 2026 in Review

Citigroup increased its Abivax (ABVX) stake by 11% in Q3 2026, buying an estimated $131K and bringing the position to 11,151 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3241.

Citigroup first reported a position in ABVX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.34M in Q2 2026. 71 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Citigroup held 11,151 shares of Abivax worth $1.1M as of Q3 2026.
  • Citigroup bought 1,090 Abivax shares in Q3 2026, an estimated $131K.
  • Abivax made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3241 holding.
  • Citigroup first reported a position in Abivax in Q1 2025 and has held it in 7 quarters since.
  • Citigroup's Abivax position peaked at $1.34M in Q2 2026.
  • 71 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.